The prevalence rate, mortality, and 5-year overall survival of Schistosoma japonicum patients with human malignancy
BackgroundOnly a few studies have focused on the association between Schistosoma japonicum and human malignancy. The aim of this study was to update the prevalence rate, mortality, and 5-year overall survival of S. japonicum patients with human malignancy.MethodsFrom January 20, 2018, to January 31,...
Main Authors: | Xue-Fei Liu, Shuai Ju, Ke-Ying Wang, Ying Li, Jin-Wei Qiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1288197/full |
Similar Items
-
Recombinant tegumental protein Shistosoma japonicum very lowdensity lipoprotein binding protein as a vaccine candidate against Schistosoma japonicum
by: Xiao-Xian Gan, et al.
Published: (2006-02-01) -
Schistosoma Japonicum Infection of the Ureter and Bladder: A Case Report and Literature Review
by: Rongchen Wang, MM, Li Qiu, MD
Published: (2023-09-01) -
Review Artikel : Perkembangan Vaksin untuk Schistosoma japonicum
by: Anis Nurwidayati
Published: (2017-02-01) -
Schistosoma japonicum infection causes a reprogramming of glycolipid metabolism in the liver
by: Zhi-Peng Xu, et al.
Published: (2019-08-01) -
Effect of RNA interference on WD101 gene of Schistosoma japonicum
by: Peng Zhang, et al.
Published: (2018-01-01)